Peer insightsfrom a CLEVIPREX® (clevidipine) user


Renowned anesthesiologist Dr. Todd Horowitz

Dr. Horowitz speaks about CLEVIPREX

Renowned anesthesiologist Dr. Horowitz discusses CLEVIPREX clinical trial results and dosing in a series of informative videos for healthcare professionals.

Todd Horowitz, DO
Medical Director, Department of Anesthesiology, Delray Medical Center
(20:50)

CLEVIPREX Clinical Trials

Dr. Horowitz discusses efficacy and safety outcomes from pivotal trials in a variety of patient types and settings, including perioperative hypertension and acute severe hypertension.

(11:58)

Dosing CLEVIPREX

Get an overview of how to properly administer and dose CLEVIPREX presented by Dr. Horowitz.


All fields are required unless otherwise indicated.








Individualized, titratable administration1

CLEVIPREX offers low-volume, non–weight-based dosing that is independent of renal or hepatic function.

50 mL and 100 mL CLEVIPREX single-use, ready-to-use vials

Proven efficacy in clinical studies1-5

CLEVIPREX provided blood pressure reduction in a range of patients and various clinical settings.


Onset within minutes1

CLEVIPREX has a titratable, fast onset of action and short half-life.